A 48-year-old woman with type 2 diabetes mellitus on metformin and glibenclamide (glyburide) presents to the emergency department with confusion, diaphoresis, tremor, and a capillary blood glucose of 42 mg/dL. She denies recent illness or change in medication. Her husband reports she had skipped breakfast 2 hours ago. After confirming hypoglycemia with a laboratory glucose measurement, what is the most appropriate immediate next step?

Explanation

## Acute Management of Severe Symptomatic Hypoglycemia **Key Point:** Severe symptomatic hypoglycemia with altered mental status (confusion) requires **immediate intravenous dextrose**, not oral glucose or glucagon, because the patient cannot reliably swallow and requires rapid correction. ### Classification of Hypoglycemia Severity | Severity | Symptoms | Management | |----------|----------|-------------| | **Mild** | Tremor, sweating, palpitations, hunger | Oral glucose (15 g fast-acting carbs) | | **Moderate** | Confusion, slurred speech, difficulty concentrating | IV dextrose OR IM glucagon (if IV access unavailable) | | **Severe** | Loss of consciousness, seizures, altered mental status | **IV dextrose 50% (25 mL bolus) STAT** | **High-Yield:** The mnemonic **"Rule of 15"** applies to mild hypoglycemia (oral route only): - Consume 15 g fast-acting carbohydrate - Wait 15 minutes - Recheck glucose - Repeat if still <100 mg/dL But this patient has **severe hypoglycemia with confusion** — oral route is contraindicated. ### Why IV Dextrose Is Correct Here 1. **Altered mental status** (confusion) = cannot safely swallow → aspiration risk 2. **Rapid correction needed** → IV dextrose works in <5 minutes vs. IM glucagon (10–15 min onset) 3. **Confirmed hypoglycemia** (glucose 42 mg/dL) → no diagnostic delay 4. **Likely sulfonylurea-induced** (glibenclamide is long-acting) → prolonged hypoglycemia risk; dextrose infusion prevents rebound **Clinical Pearl:** After IV dextrose bolus, always follow with a continuous infusion (5–10% dextrose) because sulfonylurea-induced hypoglycemia is **prolonged**. Bolus alone risks recurrent hypoglycemia as dextrose is metabolized. ```mermaid flowchart TD A["Symptomatic Hypoglycemia (glucose <70 mg/dL)"]:::outcome --> B{"Mental status intact?"}:::decision B -->|"Yes"| C["Oral glucose 15 g"]:::action C --> D["Recheck in 15 min"]:::action B -->|"No (confusion/seizure/coma)"| E{"IV access available?"}:::decision E -->|"Yes"| F["IV dextrose 50% 25 mL bolus"]:::action F --> G["Follow with 5-10% dextrose infusion"]:::action E -->|"No"| H["IM glucagon 1 mg"]:::action H --> I["Establish IV access; prepare dextrose"]:::action G --> J["Monitor glucose q15 min until stable"]:::action I --> J ``` **Tip:** Glucagon is second-line because: - Slower onset (10–15 min vs. 5 min for IV dextrose) - Ineffective if liver glycogen depleted (chronic malnutrition, alcohol use) - Can cause rebound hyperglycemia and nausea - Still useful if IV access unavailable